Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma announces expansion of POLB 001 into oncology

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.57
+0.18 (0.08%)
AAPL  339.72
+2.81 (0.83%)
AMD  459.96
-34.99 (-7.07%)
BAC  62.33
+0.20 (0.32%)
GOOG  333.26
+6.69 (2.05%)
META  596.85
+2.98 (0.50%)
MSFT  398.40
+9.30 (2.39%)
NVDA  197.44
+0.93 (0.47%)
ORCL  120.78
+0.88 (0.74%)
TSLA  306.34
-2.88 (-0.93%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.